Chemoimmunotherapy for disseminated malignant melanoma: a prospective randomized study. 1978

W L Ramseur, and F Richards, and H B Muss, and L Rhyne, and M R Cooper, and D R White, and J J Stuart, and C L Spurr

Twenty-eight patients with disseminated malignant melanoma were treated with DTIC (250 mg/m2 iv, Days 1--5) and actinomycin D (0.5 mg/day iv, Days 1--5) at 5-week intervals. Patients were randomly allocated to receive no immunotherapy or immunotherapy consisting of methanol extracted residue of bacillus Calmette-Guérin (0.5 mg intradermally; 100 microgram in five separate sites) every 5 weeks, concomitant with chemotherapy. Of these 28 evaluable patients, 13 received chemoimmunotherapy with one complete response (CR) and 15 received chemotherapy alone with one CR. Both responses occurred in lymph node metastases. No partial responses were seen.

UI MeSH Term Description Entries
D007167 Immunotherapy Manipulation of the host's immune system in treatment of disease. It includes both active and passive immunization as well as immunosuppressive therapy to prevent graft rejection. Immunotherapies
D008545 Melanoma A malignant neoplasm derived from cells that are capable of forming melanin, which may occur in the skin of any part of the body, in the eye, or, rarely, in the mucous membranes of the genitalia, anus, oral cavity, or other sites. It occurs mostly in adults and may originate de novo or from a pigmented nevus or malignant lentigo. Melanomas frequently metastasize widely, and the regional lymph nodes, liver, lungs, and brain are likely to be involved. The incidence of malignant skin melanomas is rising rapidly in all parts of the world. (Stedman, 25th ed; from Rook et al., Textbook of Dermatology, 4th ed, p2445) Malignant Melanoma,Malignant Melanomas,Melanoma, Malignant,Melanomas,Melanomas, Malignant
D009163 Mycobacterium bovis The bovine variety of the tubercle bacillus. It is called also Mycobacterium tuberculosis var. bovis. BCG,Calmette-Guerin Bacillus
D009362 Neoplasm Metastasis The transfer of a neoplasm from one organ or part of the body to another remote from the primary site. Metastase,Metastasis,Metastases, Neoplasm,Metastasis, Neoplasm,Neoplasm Metastases,Metastases
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D003606 Dacarbazine An antineoplastic agent. It has significant activity against melanomas. (from Martindale, The Extra Pharmacopoeia, 31st ed, p564) DTIC,5-(3,3-Dimethyl-1-triazeno)imidazole-4-carboxamide,Biocarbazine,DIC,DTIC-Dome,Decarbazine,Deticene,Dimethyl Imidazole Carboxamide,Dimethyl Triazeno Imidazole Carboxamide,ICDT,NSC-45388,Carboxamide, Dimethyl Imidazole,DTIC Dome,DTICDome,Imidazole Carboxamide, Dimethyl,NSC 45388,NSC45388
D003609 Dactinomycin A compound composed of a two CYCLIC PEPTIDES attached to a phenoxazine that is derived from STREPTOMYCES parvullus. It binds to DNA and inhibits RNA synthesis (transcription), with chain elongation more sensitive than initiation, termination, or release. As a result of impaired mRNA production, protein synthesis also declines after dactinomycin therapy. (From AMA Drug Evaluations Annual, 1993, p2015) Actinomycin,Actinomycin D,Meractinomycin,Cosmegen,Cosmegen Lyovac,Lyovac-Cosmegen,Lyovac Cosmegen,Lyovac, Cosmegen,LyovacCosmegen
D005069 Evaluation Studies as Topic Works about studies that determine the effectiveness or value of processes, personnel, and equipment, or the material on conducting such studies. Critique,Evaluation Indexes,Evaluation Methodology,Evaluation Report,Evaluation Research,Methodology, Evaluation,Pre-Post Tests,Qualitative Evaluation,Quantitative Evaluation,Theoretical Effectiveness,Use-Effectiveness,Critiques,Effectiveness, Theoretical,Evaluation Methodologies,Evaluation Reports,Evaluation, Qualitative,Evaluation, Quantitative,Evaluations, Qualitative,Evaluations, Quantitative,Indexes, Evaluation,Methodologies, Evaluation,Pre Post Tests,Pre-Post Test,Qualitative Evaluations,Quantitative Evaluations,Report, Evaluation,Reports, Evaluation,Research, Evaluation,Test, Pre-Post,Tests, Pre-Post,Use Effectiveness
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

W L Ramseur, and F Richards, and H B Muss, and L Rhyne, and M R Cooper, and D R White, and J J Stuart, and C L Spurr
August 1993, Melanoma research,
W L Ramseur, and F Richards, and H B Muss, and L Rhyne, and M R Cooper, and D R White, and J J Stuart, and C L Spurr
January 1981, Cancer treatment reports,
W L Ramseur, and F Richards, and H B Muss, and L Rhyne, and M R Cooper, and D R White, and J J Stuart, and C L Spurr
May 1980, Cancer,
W L Ramseur, and F Richards, and H B Muss, and L Rhyne, and M R Cooper, and D R White, and J J Stuart, and C L Spurr
October 1994, British journal of cancer,
W L Ramseur, and F Richards, and H B Muss, and L Rhyne, and M R Cooper, and D R White, and J J Stuart, and C L Spurr
January 2007, The Cochrane database of systematic reviews,
W L Ramseur, and F Richards, and H B Muss, and L Rhyne, and M R Cooper, and D R White, and J J Stuart, and C L Spurr
January 1975, The New England journal of medicine,
W L Ramseur, and F Richards, and H B Muss, and L Rhyne, and M R Cooper, and D R White, and J J Stuart, and C L Spurr
June 1978, The Australian and New Zealand journal of surgery,
W L Ramseur, and F Richards, and H B Muss, and L Rhyne, and M R Cooper, and D R White, and J J Stuart, and C L Spurr
January 1989, Medical oncology and tumor pharmacotherapy,
W L Ramseur, and F Richards, and H B Muss, and L Rhyne, and M R Cooper, and D R White, and J J Stuart, and C L Spurr
September 1974, The New England journal of medicine,
W L Ramseur, and F Richards, and H B Muss, and L Rhyne, and M R Cooper, and D R White, and J J Stuart, and C L Spurr
April 1987, American journal of clinical oncology,
Copied contents to your clipboard!